NCT00841958

Endocardial Stem Cells Approach Efficacy

Efficacy of the Endocardial Stem Cells Implantation in Ischemic Heart Failure Patients

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 250 (actual)
• Sponsor: Meshalkin Research Institute of Pathology of Circulation · Network
• Sex: All
• Age: 21 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of this study is to test that endocardial stem cells implantation in patients who have CAD, low ejection fraction and signs of HF without possibility of CABG and PCI or despite on previous revascularization improves long-term survival compared to MED alone

Conditions

• Myocardial Ischemia

Interventions

Type	Name	Description
PROCEDURE	Autologous bone marrow mononuclear stem cells or peripheral blood stem cells	Cells concentration is 150х106 cells/ml (2ml) with CD34+ cells=2.5±1.44%

Timeline

• Start date: 2007-02-01
• Primary completion: 2011-12-01
• Completion: 2011-12-01
• First posted: 2009-02-12
• Last updated: 2012-04-24

Locations

1 site across 1 country: Russia